Cleveland Clinic Taussig Cancer Institute
Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.
- 2023 Breast Cancer Update: Review of Breast Cancer Symposia
- 2023 Management of Checkpoint Inhibitor-Related Toxicity
- 2022 Management of Checkpoint Inhibitor-Related Toxicities
- 2022 Breast Cancer Update: Review of Breast Cancer Symposium
- 2021 Management of Checkpoint Inhibitor-Related Toxicity
- Breast Cancer Update: Review of Breast Cancer Symposia
- 7th Annual Multidisciplinary Colorectal Oncology Course
- ASCO 2020 Highlights
- 20th Annual ASH Review
- 2020 Management of Checkpoint Inhibitor-Related Toxicity
- 2020 Multidisciplinary Head and Neck Cancer Update
- 6th Annual Multidisciplinary Colorectal Oncology Course
- 5th Annual Cleveland Breast Cancer Summit
- 5th Annual Multidisciplinary Colorectal Oncology Course
- Breast
- GI
- GU
- Skin
- Lymphoma
- Leukemia
- Lung
- Gyn
- MDS/MPN
- Benign Hematology
- Myeloma
- Events
- Updates in Melanoma and High Risk Skin Cancer Management
Playback speed
10 seconds
81 y/o Male With RA and Stage IV Melanoma: What Is the Optimal Management of RA? Should His JAKi Be Continued Concurrently With IO?
69 views
March 19, 2021
Login to view comments.
Click here to Login
2021 Management of Checkpoint Inhibitor-Related Toxicity